Invention Grant
- Patent Title: Quaternary ammonium salt compounds
- Patent Title (中): 季铵盐化合物
-
Application No.: US13266651Application Date: 2010-04-27
-
Publication No.: US09072734B2Publication Date: 2015-07-07
- Inventor: Etsuko Mitsuyama , Takayuki Hara , Junji Igarashi , Hiroyuki Sugiyama , Satoshi Yamamura , Johji Nomura , Kei Segawa
- Applicant: Etsuko Mitsuyama , Takayuki Hara , Junji Igarashi , Hiroyuki Sugiyama , Satoshi Yamamura , Johji Nomura , Kei Segawa
- Applicant Address: JP Tokyo
- Assignee: Teijin Pharma Limited
- Current Assignee: Teijin Pharma Limited
- Current Assignee Address: JP Tokyo
- Agency: Sughrue Mion, PLLC
- Priority: JP2009-110760 20090430
- International Application: PCT/JP2010/057422 WO 20100427
- International Announcement: WO2010/126025 WO 20101104
- Main IPC: A61K31/445
- IPC: A61K31/445 ; C07D215/16 ; A61K31/4709 ; C07D401/12 ; C07D413/12 ; C07D417/12 ; C07D491/18
Abstract:
[Problem]The object of the present invention is to provide a novel compound having β2 adrenergic receptor agonist activity and muscarinic receptor antagonist activity.[Means for Solving the Problem]The present invention is a quaternary ammonium salt compounds represented by formula (I), or a pharmaceutically acceptable salt thereof, with superior β2 adrenergic receptor agonist activity and muscarinic receptor antagonist activity.
Public/Granted literature
- US20120046467A1 QUATERNARY AMMONIUM SALT COMPOUNDS Public/Granted day:2012-02-23
Information query
IPC分类:
